Mark R. Litzow
Active 1993–2025
- 313
- Papers
- 41,883
- Citations
- 110
- h-index
- 291
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine80.6%
- Biochemistry, Genetics and Molecular Biology13.7%
- Immunology and Microbiology4.1%
- Computer Science0.2%
- Economics, Econometrics and Finance0.2%
- Engineering0.2%
- Other1%
Topics
- Acute Myeloid Leukemia Research11.1%
- Acute Lymphoblastic Leukemia research6.8%
- Hematopoietic Stem Cell Transplantation6.4%
- Chronic Myeloid Leukemia Treatments5.4%
- CAR-T cell therapy research4.4%
- Myeloproliferative Neoplasms: Diagnosis and Treatment4.1%
- Other61.8%
Coauthors
- William J. Hogan67
- Ayalew Tefferi58
- Martin S. Tallman54
- Aref Al‐Kali52
- Elisabeth Paietta49
- Hillard M. Lazarus49
- Mrinal M. Patnaik49
- Selina M. Luger49
- Hassan B. Alkhateeb47
- Mithun Vinod Shah41
- Naseema Gangat41
- Jacob M. Rowe37
- James M. Foran36
- Kebede H. Begna35
- Animesh Pardanani33
- Talha Badar33
- Abhishek A. Mangaonkar31
- Harry P. Erba29
- Martha Q. Lacy29
- Morie A. Gertz29
- Angela Dispenzieri28
- David I. Marks28
- Robert Peter Gale27
- Wendy Stock26
All papers
- International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium
Authors: Andrew C. Harris, Rachel Young, Steven M. Devine, William J. Hogan, Francis Ayuk, Udomsak Bunworasate, Chantiya Chanswangphuwana, Yvonne A. Efebera, Ernst Holler, Mark R. Litzow, Rainer Ordemann, Muna Qayed, Anne S. Renteria, Ran Reshef, Matthias Wölfl, Yi‐Bin Chen, Steven C. Goldstein, Madan Jagasia, Franco Locatelli, Stephan Mielke, David Porter, Tal Schechter, Zhanna Shekhovtsova, James L.M. Ferrara, John E. Levine - Biology of Blood and Marrow Transplantation 2015 cited by 960
- Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
Authors: Max S. Topp, Nicola Gökbuget, Anthony S. Stein, Gerhard Zugmaier, Susan O’Brien, Ralf C. Bargou, Hervé Dombret, Adele K. Fielding, Leonard T. Heffner, Richard A Larson, Svenja Neumann, Robin Foà, Mark R. Litzow, Josep‐María Ribera, Alessandro Rambaldi, Gary J. Schiller, Monika Brüggemann, Heinz A. Horst, Chris Holland, Catherine Jia, Tapan Maniar, Birgit Huber, Dirk Nagorsen, Stephen J. Forman, Hagop M. Kantarjian - The Lancet Oncology 2014 cited by 1,259
- Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL
Authors: Jennifer A. Woyach, Amy S. Ruppert, Nyla A. Heerema, Weiqiang Zhao, Allison M. Booth, Wei Ding, Nancy L. Bartlett, Danielle M. Brander, Paul M. Barr, Kerry A. Rogers, Sameer A. Parikh, Steven Coutré, Arti Hurria, Jennifer R. Brown, Gerard Lozanski, James S. Blachly, Hatice Gülçin Özer, Brittny Major‐Elechi, Briant Fruth, Sreenivasa Nattam, Richard A. Larson, Harry P. Erba, Mark R. Litzow, Carolyn Owen, Charles Kuzma, Jeremy S. Abramson, Richard F. Little, Scott E. Smith, Richard M. Stone, Sumithra J. Mandrekar, John C. Byrd - New England Journal of Medicine 2018 cited by 952
- Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia
Authors: Naval Daver, Alexander E. Perl, Joseph Maly, Mark J. Levis, Ellen K. Ritchie, Mark R. Litzow, James McCloskey, Catherine C. Smith, Gary J. Schiller, Terrence Bradley, Ramón V. Tiu, Kiran Naqvi, Monique Dail, Deanna J. Brackman, Satya R. Siddani, Jing Wang, Brenda Chyla, Paul Lee, Jessica K. Altman - Journal of Clinical Oncology 2022 cited by 187
- PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
Authors: Zhaohui Gu, Michelle L. Churchman, Kathryn G. Roberts, Ian Moore, Xin Zhou, Joy Nakitandwe, Kohei Hagiwara, S. William Pelletier, Sébastien Gingras, Hartmut Berns, Debbie Payne-Turner, Ashley Hill, Ilaria Iacobucci, Lei Shi, Stanley Pounds, Cheng Cheng, Deqing Pei, Chunxu Qu, Scott Newman, Meenakshi Devidas, Yunfeng Dai, Shalini C. Reshmi, Julie M. Gastier‐Foster, Elizabeth A. Raetz, Michael J. Borowitz, Brent L. Wood, William L. Carroll, Patrick A. Zweidler‐McKay, Karen R. Rabin, Leonard A. Mattano, Kelly W. Maloney, Alessandro Rambaldi, Orietta Spinelli, Jerald P. Radich, Mark D. Minden, Jacob M. Rowe, Selina M. Luger, Mark R. Litzow, Martin S. Tallman, Janis Racevskis, Yanming Zhang, Ravi Bhatia, Jessica Kohlschmidt, Krzysztof Mrózek, Clara D. Bloomfield, Wendy Stock, Steven M. Kornblau, Hagop M. Kantarjian, Marina Konopleva, Williams E. Evans, Sima Jeha, Ching‐Hon Pui, Jun J. Yang, Elisabeth Paietta, James R. Downing, Mary V. Relling, Jinghui Zhang, Mignon L. Loh, Stephen P. Hunger, Charles G. Mullighan - Nature Genetics 2019 cited by 617
- Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
Authors: Tait D. Shanafelt, Xin V. Wang, Neil E. Kay, Curtis A. Hanson, Susan O’Brien, Jacqueline C. Barrientos, Diane F. Jelinek, Esteban Braggio, José F. Leis, Cong C. Zhang, Steven Coutré, Paul M. Barr, Amanda F. Cashen, Anthony R. Mato, Avina K. Singh, Michael P. Mullane, Richard F. Little, Harry P. Erba, Richard M. Stone, Mark R. Litzow, Martin S. Tallman - New England Journal of Medicine 2019 cited by 738
- Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial
Authors: Tait D. Shanafelt, Victoria Wang, Curtis A. Hanson, Elisabeth Paietta, Susan O’Brien, Jacqueline C. Barrientos, Diane F. Jelinek, Esteban Braggio, José F. Leis, Cong Christine Zhang, Steven Coutré, Paul M. Barr, Amanda F. Cashen, Anthony R. Mato, Avina K. Singh, Michael P. Mullane, Richard F. Little, Harry P. Erba, Richard M. Stone, Mark R. Litzow, Martin S. Tallman, Neil E. Kay - Blood 2022 cited by 237
- Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
Authors: Jay P. Patel, Mithat Gönen, María E. Figueroa, Hugo F. Fernández, Zhuoxin Sun, Janis Racevskis, Pieter Van Vlierberghe, Igor Dolgalev, Sabrena Thomas, Olga Aminova, Kety Huberman, Janice Cheng, Agnès Viale, Nicholas D. Socci, Adriana Heguy, Athena M. Cherry, Gail H. Vance, Rodney R. Higgins, Rhett P. Ketterling, Robert E. Gallagher, Mark R. Litzow, Marcel R.M. van den Brink, Hillard M. Lazarus, Jacob M. Rowe, Selina M. Luger, Adolfo A. Ferrando, Elisabeth Paietta, Martin S. Tallman, Ari Melnick, Omar Abdel‐Wahab, Ross L. Levine - New England Journal of Medicine 2012 cited by 1,948
- Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3
Authors: Mark J. Levis, Mehdi Hamadani, Brent R. Logan, Richard J. Jones, Anurag K. Singh, Mark R. Litzow, John R. Wingard, Esperanza B. Papadopoulos, Alexander E. Perl, Robert J. Soiffer, Celalettin Üstün, Masumi Ueda, Geoffrey L. Uy, Edmund K. Waller, Sumithra Vasu, Melhem Solh, Asmita Mishra, Lori Muffly, Hee‐Je Kim, Jan‐Henrik Mikesch, Yuho Najima, Masahiro Onozawa, Kirsty Thomson, Arnon Nagler, Andrew H. Wei, Guido Marcucci, Nancy L. Geller, Nahla Hasabou, David Delgado, Matt Rosales, Jason E. Hill, Stanley C. Gill, Rishita Nuthethi, Denise King, Heather Wittsack, Adam Mendizabal, Steven M. Devine, Mary M. Horowitz, Yi‐Bin Chen, on behalf of the BMT-CTN 1506/MORPHO Study Investigators, Ed Agura, Jessica K. Altman, Achiles Anagnostopoulos, Sarah Anand, Andrew Artz, Walter E. Aulitzky, Sophia Balderman, Karen K. Ballen, Michael W. Becker, Yves Béguin, Leanne Berkahn, Zwi Berneman, Vijaya Raj Bhatt, Ian Bilmon, Francesca Bonifazi, Adrienne Briggs, Benedetto Bruno, Claudio G. Brunstein, Michael Byrne, Jenny Byrne, Mónica Cabrero, Roberto Cairoli, George Carrum, Jan Černý, Yi‐Bin Chen, June‐Won Cheong, Fabio Ciceri, Mercedes Colorado, Rachel J. Cook, Daniel R. Couriel, Charles Craddock, Lloyd E. Damon, Abhinav Deol, Yohan Desbrosses, Steve Devine, Carmela Di Grazia, Antonio Di Stasi, Ajoy Dias, Kathy Dorritie, James Essell, Tetsuya Eto, Sherif S. Farag, Édouard Forcade, Olga Frankfurt, Shin‐ichiro Fujiwara, Takahiro Fukuda, Kentaro Fukushima, Sabine Fürst, Tatsunori Goto, Aric C. Hall, Shunsuke Hatta, Yosr Hicheri, Mitchell E. Horwitz, Hsin‐An Hou, Jonathan How, Dianna S. Howard, Wei‐Hsun Hsu, Anne Huynh, David Irvine, Takayuki Ishikawa and 109 more - Journal of Clinical Oncology 2024 cited by 185
- A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403
Authors: Wendy Stock, Selina M. Luger, Anjali S. Advani, Jun Yin, Richard C. Harvey, Charles G. Mullighan, Cheryl L. Willman, Noreen Fulton, Kristina Laumann, Greg Malnassy, Elisabeth Paietta, Edy Parker, Susan Geyer, Krzysztof Mrózek, Clara D. Bloomfield, Ben L. Sanford, Guido Marcucci, Michaela Liedtke, David F. Claxton, Matthew C. Foster, Jeffrey A. Bogart, J.C. Grecula, Frederick R. Appelbaum, Harry P. Erba, Mark R. Litzow, Martin S. Tallman, Richard M. Stone, Richard A. Larson - Blood 2019 cited by 471
- Palliative Care for Patients With Cancer: ASCO Guideline Update
Authors: Justin J. Sanders, Sarah Temin, Arunangshu Ghoshal, Erin R. Alesi, Zipporah Ali, Cynthia Chauhan, James F. Cleary, Andrew S. Epstein, Janice Firn, J Jones, Mark R. Litzow, Debra Lundquist, Mabel Alejandra Mardones, Ryan David Nipp, Michael W. Rabow, William E. Rosa, Camilla Zimmermann, Betty Ferrell - Journal of Clinical Oncology 2024 cited by 279
- Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults
Authors: Mark R. Litzow, Zhuoxin Sun, Ryan J. Mattison, Elisabeth Paietta, Kathryn G. Roberts, Yanming Zhang, Janis Racevskis, Hillard M. Lazarus, Jacob M. Rowe, Daniel A. Arber, Matthew J. Wieduwilt, Michaela Liedtke, Julie Bergeron, Brent L. Wood, Yaqi Zhao, Gang Wu, Ti‐Cheng Chang, Wen-Chao Zhang, Keith W. Pratz, Shira Dinner, Noelle V. Frey, Steven D. Gore, Bhavana Bhatnagar, Ehab Atallah, Geoffrey L. Uy, Deepa Jeyakumar, Tara L. Lin, Cheryl L. Willman, Daniel J. DeAngelo, Shejal Patel, Michelle A. Elliott, Anjali S. Advani, Dimitrios Tzachanis, Pankit Vachhani, Rupali Bhave, Elad Sharon, Richard F. Little, Harry P. Erba, Richard M. Stone, Selina M. Luger, Charles G. Mullighan, Martin S. Tallman - New England Journal of Medicine 2024 cited by 215
- DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant
Authors: Laura W. Dillon, Gege Gui, Kristin Page, Niveditha Ravindra, Zoë C. Wong, Georgia Andrew, Devdeep Mukherjee, Scott L. Zeger, Firas El Chaer, Stephen R. Spellman, Alan Howard, Karen Chen, Jeffery J. Auletta, Steven M. Devine, Antonio Jiménez, Marcos J.G. De Lima, Mark R. Litzow, Partow Kebriaei, Wael Saber, Daniel J. Weisdorf, Christopher S. Hourigan - JAMA 2023 cited by 144
- Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia
Authors: Lindsey E. Montefiori, Sonja Bendig, Zhaohui Gu, Xiaolong Chen, Petri Pölönen, Xiaotu Ma, Alex Murison, Andy G.X. Zeng, Laura García‐Prat, Kirsten Dickerson, Ilaria Iacobucci, Sherif Abdelhamed, Ryan Hiltenbrand, Paul E. Mead, Cyrus M. Mehr, Beisi Xu, Zhongshan Cheng, Ti‐Cheng Chang, Tamara Westover, Jing Ma, Anna Stengel, Shunsuke Kimura, Chunxu Qu, Marcus B. Valentine, Marissa Rashkovan, Selina M. Luger, Mark R. Litzow, Jacob M. Rowe, Monique L. den Boer, Victoria Wang, Jun Yin, Steven M. Kornblau, Stephen P. Hunger, Mignon L. Loh, Ching‐Hon Pui, Wenjian Yang, Kristine R. Crews, Kathryn G. Roberts, Jun J. Yang, Mary V. Relling, William E. Evans, Wendy Stock, Elisabeth Paietta, Adolfo A. Ferrando, Jinghui Zhang, Wolfgang Kern, Torsten Haferlach, Gang Wu, John E. Dick, Jeffery M. Klco, Claudia Haferlach, Charles G. Mullighan - Cancer Discovery 2021 cited by 188
- Anthracycline Dose Intensification in Acute Myeloid Leukemia
Authors: Hugo F. Fernández, Zhuoxin Sun, Xiaopan Yao, Mark R. Litzow, Selina M. Luger, Elisabeth Paietta, Janis Racevskis, Gordon W. Dewald, Rhett P. Ketterling, John M. Bennett, Jacob M. Rowe, Hillard M. Lazarus, Martin S. Tallman - New England Journal of Medicine 2009 cited by 907
- A dynamic N6-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors
Authors: Fei Yan, Aref Al‐Kali, Zijie Zhang, Jun Liu, Jiuxia Pang, Na Zhao, Chuan He, Mark R. Litzow, Shujun Liu - Cell Research 2018 cited by 256
- Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Authors: Patrick A. Brown, Bijal Shah, Anjali S. Advani, Patricia Aoun, Michael W. Boyer, Patrick W. Burke, Daniel J. DeAngelo, Shira Dinner, Amir T. Fathi, Jordan Gauthier, Nitin Jain, Suzanne Kirby, Michaela Liedtke, Mark R. Litzow, Aaron C. Logan, Selina M. Luger, Lori J. Maness, Stephanie Massaro, Ryan J. Mattison, William May, Olalekan O. Oluwole, Jae H. Park, Amanda Przespolewski, Sravanti Rangaraju, Jeffrey E. Rubnitz, Geoffrey L. Uy, Madhuri Vusirikala, Matthew J. Wieduwilt, Beth Lynn, Ryan A. Berardi, Deborah A. Freedman-Cass, Mallory Campbell - Journal of the National Comprehensive Cancer Network 2021 cited by 241
- Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients
Authors: Naseema Gangat, Omer Karrar, Moazah Iftikhar, Kristen McCullough, Isla McKerrow Johnson, Maymona Abdelmagid, Mostafa Abdallah, Aref Al‐Kali, Hassan B. Alkhateeb, Kebede H. Begna, Abhishek A. Mangaonkar, Antoine N. Saliba, Mehrdad Hefazi, Mark R. Litzow, William J. Hogan, Mithun Vinod Shah, Mrinal M. Patnaik, Animesh Pardanani, Talha Badar, Hemant S. Murthy, James M. Foran, Jeanne Palmer, Lisa Sproat, Nandita Khera, Cecilia Y. Arana Yi, Ayalew Tefferi - American Journal of Hematology 2023 cited by 75
- High Frequency and Poor Outcome of Philadelphia Chromosome–Like Acute Lymphoblastic Leukemia in Adults
Authors: Kathryn G. Roberts, Zhaohui Gu, Debbie Payne-Turner, Kelly McCastlain, Richard C. Harvey, I‐Ming Chen, Deqing Pei, Ilaria Iacobucci, Marcus B. Valentine, Stanley Pounds, Lei Shi, Yongjin Li, Jinghui Zhang, Cheng Cheng, Alessandro Rambaldi, Manuela Tosi, Orietta Spinelli, Jerald P. Radich, Mark D. Minden, Jacob M. Rowe, Selina M. Luger, Mark R. Litzow, Martin S. Tallman, Peter H. Wiernik, Ravi Bhatia, Ibrahim Aldoss, Jessica Kohlschmidt, Krzysztof Mrózek, Guido Marcucci, Clara D. Bloomfield, Wendy Stock, Stephen Kornblau, Hagop M. Kantarjian, Marina Konopleva, Elisabeth Paietta, Cheryl L. Willman, Charles G. Mullighan - Journal of Clinical Oncology 2017 cited by 449
- Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor–Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies
Authors: Leo Luznik, Marcelo C. Pasquini, Brent Logan, Robert J. Soiffer, Juan Wu, Steven M. Devine, Nancy Geller, Sergio Giralt, Helen E. Heslop, Mary M. Horowitz, Richard J. Jones, Mark R. Litzow, Adam Mendizabal, Lori Muffly, Eneida R. Nemecek, Lynn O'Donnell, Richard J. O'Reilly, Raquel Palencia, Johannes Schetelig, Leyla Shune, Scott R. Solomon, Sumithira Vasu, Vincent T. Ho, Miguel-Angel Perales - Journal of Clinical Oncology 2021 cited by 168
- Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia
Authors: Yoshihiro Gocho, Jingjing Liu, Jianzhong Hu, Wentao Yang, Neekesh V. Dharia, Jingliao Zhang, Hao Shi, Guoqing Du, August John, Ting-Nien Lin, Jeremy P. Hunt, Xin Huang, Bensheng Ju, Lauren Rowland, Lei Shi, Dylan Maxwell, Brandon Smart, Kristine R. Crews, Wenjian Yang, Kohei Hagiwara, Yingchi Zhang, Kathryn G. Roberts, Hong Wang, Elias Jabbour, Wendy Stock, Bartholomew J. Eisfelder, Elisabeth Paietta, Scott Newman, Giovanni Roti, Mark R. Litzow, John Easton, Jinghui Zhang, Junmin Peng, Hongbo Chi, Stanley Pounds, Mary V. Relling, Hiroto Inaba, Xiaofan Zhu, Steven M. Kornblau, Ching‐Hon Pui, Marina Konopleva, David T. Teachey, Charles G. Mullighan, Kimberly Stegmaier, William E. Evans, Jiyang Yu, Jun J. Yang - Nature Cancer 2021 cited by 157
- Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study
Authors: Adele K. Fielding, Susan Richards, Rajesh Chopra, Hillard M. Lazarus, Mark R. Litzow, Georgina Buck, Ian Durrant, Selina M. Luger, David I. Marks, Ian M. Franklin, Andrew McMillan, Martin S. Tallman, Jacob M. Rowe, Anthony H. Goldstone - Blood 2006 cited by 843
- Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study
Authors: Alexander E. Perl, Jessica K. Altman, Jörge E. Cortes, Catherine C. Smith, Mark R. Litzow, Maria R. Baer, David F. Claxton, Harry P. Erba, Stan Gill, Stuart L. Goldberg, Joseph G. Jurcic, Richard A Larson, Chaofeng Liu, Ellen K. Ritchie, Gary J. Schiller, Alexander I. Spira, Stephen A. Strickland, Raoul Tibes, Celalettin Üstün, Eunice S. Wang, Robert K. Stuart, Christoph Röllig, Andreas Neubauer, Giovanni Martinelli, Erkut Bahceci, Mark J. Levis - The Lancet Oncology 2017 cited by 488
- Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial
Authors: Amy Burd, Ross L. Levine, Amy S. Ruppert, Alice S. Mims, Uma Borate, Eytan M. Stein, Prapti A. Patel, Maria R. Baer, Wendy Stock, Michael W. Deininger, William Blum, Gary J. Schiller, Rebecca L. Olin, Mark R. Litzow, James M. Foran, Tara L. Lin, Brian Ball, Michael Boyiadzis, Elie Traer, Olatoyosi Odenike, Martha Arellano, Alison Walker, Vu H. Duong, Tibor Kovacsovics, Robert H. Collins, Abigail B. Shoben, Nyla A. Heerema, Matthew C. Foster, Jo-Anne Vergilio, Timothy J. Brennan, Christine Vietz, Eric A. Severson, Molly Miller, Leonard Rosenberg, Sonja Marcus, Ashley O. Yocum, Timothy F. Chen, Mona Stefanos, Brian Druker, John C. Byrd - Nature Medicine 2020 cited by 192
